Position in NTRA
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$479,923
+$161,739 QoQ
Shares Held
1,768
+11.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#541
of 844 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Wedmont Private Capital holds $6,424,411 across 11 Diagnostics & Research names. NTRA ranks #7 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
3,086 | $1,624,593 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,615 | $809,696 | |
| 3 | A |
Agilent Technologies, Inc.
|
5,599 | $743,715 | |
| 4 | DGX |
Quest Diagnostics Inc
|
3,120 | $661,284 | |
| 5 | DHR |
Danaher Corp /De/
|
2,982 | $568,011 | |
| 6 | ILMN |
Illumina, Inc.
|
3,025 | $531,885 | |
| 7 | NTRA |
Natera, Inc.
This page
|
1,768 | $479,923 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,115 | $312,200 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,923 | 1,768 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $318,184 | 1,591 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $370,438 | 1,617 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $235,982 | 1,466 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $266,925 | 1,580 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $212,963 | 1,506 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||